These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 33432947)
1. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947 [TBL] [Abstract][Full Text] [Related]
2. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094 [TBL] [Abstract][Full Text] [Related]
3. Effect of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on gluconeogenesis in proximal renal tubules. Kim JH; Ko HY; Wang HJ; Lee H; Yun M; Kang ES Diabetes Obes Metab; 2020 Mar; 22(3):373-382. PubMed ID: 31692240 [TBL] [Abstract][Full Text] [Related]
5. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway. Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476 [TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats. Swe MT; Thongnak L; Jaikumkao K; Pongchaidecha A; Chatsudthipong V; Lungkaphin A Clin Sci (Lond); 2019 Dec; 133(23):2415-2430. PubMed ID: 31769484 [TBL] [Abstract][Full Text] [Related]
7. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice. De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289 [TBL] [Abstract][Full Text] [Related]
8. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice. Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Sodium-Glucose Cotransporter-2 during Serum Deprivation Increases Hepatic Gluconeogenesis via the AMPK/AKT/FOXO Signaling Pathway. Lee J; Hong SW; Kim MJ; Lim YM; Moon SJ; Kwon H; Park SE; Rhee EJ; Lee WY Endocrinol Metab (Seoul); 2024 Feb; 39(1):98-108. PubMed ID: 38171209 [TBL] [Abstract][Full Text] [Related]
10. Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice. Jia Y; He J; Wang L; Su L; Lei L; Huang W; Geng X; Zhang S; Meng X; Zhou H; Yang B Cell Physiol Biochem; 2018; 45(5):1747-1758. PubMed ID: 29495021 [TBL] [Abstract][Full Text] [Related]
11. Jieduquyuziyin Prescription alleviates hepatic gluconeogenesis via PI3K/Akt/PGC-1α pathway in glucocorticoid-induced MRL/lpr mice. Ji LN; Wu S; Fu DQ; Fang SJ; Xie GQ; Fan YS; Bao J J Ethnopharmacol; 2022 Feb; 284():114815. PubMed ID: 34763039 [TBL] [Abstract][Full Text] [Related]
12. Long-term co-administration of sodium nitrite and sodium hydrosulfide inhibits hepatic gluconeogenesis in male type 2 diabetic rats: Role of PI3K-Akt-eNOS pathway. Jeddi S; Gheibi S; Carlström M; Kashfi K; Ghasemi A Life Sci; 2021 Jan; 265():118770. PubMed ID: 33212150 [TBL] [Abstract][Full Text] [Related]
13. FXR activation alleviates tacrolimus-induced post-transplant diabetes mellitus by regulating renal gluconeogenesis and glucose uptake. Li L; Zhao H; Chen B; Fan Z; Li N; Yue J; Ye Q J Transl Med; 2019 Dec; 17(1):418. PubMed ID: 31836014 [TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction. Liu Q; Zhang FG; Zhang WS; Pan A; Yang YL; Liu JF; Li P; Liu BL; Qi LW Theranostics; 2017; 7(16):4001-4012. PubMed ID: 29109794 [No Abstract] [Full Text] [Related]
15. Mibefradil reduces hepatic glucose output in HepG2 cells via Ca Ying D; Mengya S; Peilin L; Lingong Z; Huan M; Jing X; Le Z; Kebin Z; Bin C; Jun Y; Shaodong G; Zihui X Eur J Pharmacol; 2021 Sep; 907():174296. PubMed ID: 34224697 [TBL] [Abstract][Full Text] [Related]
17. Glutamine administration promotes hepatic glucose homeostasis through regulating the PI3K/Akt pathway in high-fat diet-induced obese mice with limb ischemia. Pitaloka DMI; Ko CH; Lin MT; Yeh SL; Yeh CL Nutr Res; 2019 Aug; 68():45-53. PubMed ID: 31419579 [TBL] [Abstract][Full Text] [Related]
18. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade. Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D Deficiency Induces Insulin Resistance and Re-Supplementation Attenuates Hepatic Glucose Output via the PI3K-AKT-FOXO1 Mediated Pathway. Mutt SJ; Raza GS; Mäkinen MJ; Keinänen-Kiukaanniemi S; Järvelin MR; Herzig KH Mol Nutr Food Res; 2020 Jan; 64(1):e1900728. PubMed ID: 31797544 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway. Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]